Journal Article

Cytokine enrichment in deep cerebellar nuclei is contributed by multiple glial populations and linked to reduced amyloid plaque pathology

Chen, Albert I., Ch’ng, Toh Hean, Yip, Alaric K. K., Tan, Jia Min, Zainolabidin, Norliyana, Gaunt, Jessica R., Low, Aloysius Y. T.

2023

Overview

Alzheimer’s disease (AD) pathology and amyloid-beta (Aβ) plaque deposition progress slowly in the cerebellum compared to other brain regions, while the entorhinal cortex (EC) is one of the most vulnerable regions. Using a knock-in AD mouse model ( App KI), we show that within the cerebellum, the deep cerebellar nuclei (DCN) has particularly low accumulation of Aβ plaques. To identify factors that might underlie differences in the progression of AD-associated neuropathology across regions, we profiled gene expression in single nuclei (snRNAseq) across all cell types in the DCN and EC of wild-type (WT) and App KI male mice at age 7 months. We found differences in expression of genes associated with inflammatory activation, PI3K–AKT signalling, and neuron support functions between both regions and genotypes. In WT mice, the expression of interferon-response genes in microglia is higher in the DCN than the EC and this enrichment is confirmed by RNA in situ hybridisation, and measurement of inflammatory cytokines by protein array. Our analyses also revealed that multiple glial populations are responsible for establishing this cytokine-enriched niche. Furthermore, homogenates derived from the DCN induced inflammatory gene expression in BV2 microglia. We also assessed the relationship between the DCN microenvironment and Aβ pathology by depleting microglia using a CSF1R inhibitor PLX5622 and saw that, surprisingly, the expression of a subset of inflammatory cytokines was increased while plaque abundance in the DCN was further reduced. Overall, our study revealed the presence of a cytokine-enriched microenvironment unique to the DCN that when modulated, can alter plaque deposition.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: 1-Phosphatidylinositol 3-kinase / AKT protein / Alzheimer Disease - pathology / Alzheimer's disease / Amyloid beta-Peptides - metabolism / Amyloid beta-Protein Precursor - genetics / Amyloid beta-Protein Precursor - metabolism / Animals / Biomedical and Life Sciences / Biomedicine / Brain / Cerebellar Nuclei - metabolism / Cerebellar Nuclei - pathology / Cerebellum / Cortex (entorhinal) / CSF1R inhibitor / Cytokines / Cytokines - genetics / Cytokines - metabolism / Deep cerebellar nuclei / Disease Models, Animal / Entorhinal cortex / Gene expression / Genotypes / Hybridization / Immunology / Inflammation / Interferon / Male / Mice / Mice, Transgenic / Microenvironments / Microglia / Microglia - metabolism / Mutation / Neurobiology / Neurodegenerative diseases / Neurology / Neurosciences / Pathology / Phosphatidylinositol 3-Kinases - metabolism / Plaque, Amyloid - pathology / Protein arrays / Proteins / Senile plaques / Transcription activation / β-Amyloid